New hope for hepatitis b: experimental therapies aim to suppress the virus
NCT ID NCT05612581
First seen Dec 17, 2025 · Last updated Jun 04, 2026 · Updated 22 times
Summary
This study tested new experimental treatments for adults with chronic hepatitis B, a long-term liver infection. A total of 33 participants received different combinations of investigational drugs. The main goal was to see if these treatments could lower the virus to undetectable levels and reduce a key marker of infection (HBsAg).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigative Site
Clichy, 92110, France
-
Investigative Site
Nice, 06200, France
-
Investigative Site
Rennes, 35000, France
-
Investigative Site
Toulouse, 31000, France
-
Investigative Site
Hong Kong, Sha Tin, Hong Kong
-
Investigative Site
Hong Kong, Hong Kong
-
Investigative Site
Chisinau, MD 2025, Moldova
-
Investigative Site
Bucharest, 021105, Romania
-
Investigative Site
Busan, 49241, South Korea
-
Investigative Site
Seoul, 5505, South Korea
-
Investigative Site
Yangsan, 50612, South Korea
-
Investigative Site
Glasgow, G4 0SF, United Kingdom
-
Investigative Site
London, EC1A 7BE, United Kingdom
-
Investigative Site
London, SE5 9RS, United Kingdom
-
Investigative Site
Manchester, M8 5RB, United Kingdom
Conditions
Explore the condition pages connected to this study.